Evaluation of the impact of letters to GP practices to promote asthma prescription uptake in school-age children during summer (TRAINS study): a pragmatic cluster-randomised controlled trial

Rami A Alyami; Rebecca Simpson; Phillip Oliver; Steven A Julious

doi:10.1016/S0140-6736(23)02089-5

Evaluation of the impact of letters to GP practices to promote asthma prescription uptake in school-age children during summer (TRAINS study): a pragmatic cluster-randomised controlled trial

Lancet. 2023 Nov:402 Suppl 1:S22. doi: 10.1016/S0140-6736(23)02089-5.

Authors

Rami A Alyami¹, Rebecca Simpson², Phillip Oliver³, Steven A Julious²

Affiliations

¹ School of Medicine and Population Health, University of Sheffield, Sheffield, UK; Respiratory Therapy Department, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia. Electronic address: rahalyami1@sheffield.ac.uk.
² School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
³ School of Medicine and Population Health, University of Sheffield, Sheffield, UK; Academic Unit of Primary Medical Care, Samuel Fox House Northern General Hospital, Sheffield, UK.

PMID: 37997062
DOI: 10.1016/S0140-6736(23)02089-5

Abstract

Background: Asthma exacerbations peak in school-aged children after the return to school in September. Previous studies have shown a decline in collections of asthma prescriptions during August. The PLEASANT trial demonstrated that sending a reminder letter to parents increased prescription uptake; reduced unscheduled care, and was cost saving to the health service. We aimed to assess whether informing general practitioner (GP) practices about the PLEASANT trial and its results could lead to its implementation in routine practice.

Methods: The trial to assess implementation of new research in a primary care setting (TRAINS) was a pragmatic cluster-randomised (1:1) trial conducted in England involving GP practices contributing to the Clinical Practice Research Datalink (CPRD). The intervention was a letter informing the GP practice of the PLEASANT trial results with recommendations for implementation. GP practices in the control group continued with usual care without receiving any letters about PLEASANT trial. The intervention was distributed via CPRD by both mail and email in June 2021. The trial received both University of Sheffield Ethics approval and Independent Scientific Advisory Committee (ISAC) approval. The primary outcome was the proportion of children with asthma (aged 4-15 years) who had a prescription for a preventer between Aug 1 and Sept 30, 2021. This trial is registered with ClinicalTrials.gov, NCT05226091.

Findings: A total of 1326 GP practices, including 90 583 children with asthma, were included in the study. These practices were randomly allocated to the intervention group (664 practices, 44 708 children) or the control group (662 practices, 45 875 children). In assessing the impact of the intervention on the proportion of children collecting a preventer prescription, 15 716 (35·3%) of 44 708 children from the intervention group and 16 001 (35·1%) of 45 559 children from the control group picked up a prescription. There was no statistically significant difference observed (odds ratio [OR] 1·01, 95% CI 0·97-1·05), indicating that the intervention had no effect.

Interpretation: The study findings suggest that passive intervention of providing a letter to GPs did not achieve the intended outcomes. To bridge the gap between evidence and practice, alternative, more proactive strategies could be explored to address the identified issues.

Funding: Jazan University.

Publication types

Pragmatic Clinical Trial
Randomized Controlled Trial

MeSH terms

Asthma* / drug therapy
Child
Cost-Benefit Analysis
General Practice*
General Practitioners*
Humans
Prescriptions

Associated data

ClinicalTrials.gov/NCT05226091